Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Johnson

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer modelsPatrick J Roberts, Jerry E Usary, David B Darr, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2019
Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphomaJason P Wong, Timothy J Stuhlmiller, Louise C Giffin, et al.
JCI Insight|March 28, 2020
Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapyMatthew B Lipner, Xianlu L Peng, Chong Jin, et al.
The American Journal of Pathology|November 30, 2005
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine modelRobert S Stearman, Lori Dwyer-Nield, Laura Zerbe, et al.
Oncotarget|April 13, 2018
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancerKyla A L Collins, Timothy J Stuhlmiller, Jon S Zawistowski, et al.
Elife|May 11, 2021
Limited inhibition of multiple nodes in a driver network blocks metastasisAli Ekrem Yesilkanal, Dongbo Yang, Andrea Valdespino, et al.
Molecular Cancer Therapeutics|February 5, 2025
Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastomaSmita Matkar, Michael P East, Timothy J Stuhlmiller, et al.
Antiviral Research|June 23, 2022
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategiesMarwah Karim, Sirle Saul, Luca Ghita, et al.
Neuro-Oncology|July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningiomaSteven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2026
Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancersMatthew D Sutcliffe, Kevin R Mott, Tulay Yilmaz-Swenson, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer modelsPatrick J Roberts, Jerry E Usary, David B Darr, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2019
Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphomaJason P Wong, Timothy J Stuhlmiller, Louise C Giffin, et al.
JCI Insight|March 28, 2020
Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapyMatthew B Lipner, Xianlu L Peng, Chong Jin, et al.
The American Journal of Pathology|November 30, 2005
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine modelRobert S Stearman, Lori Dwyer-Nield, Laura Zerbe, et al.
Oncotarget|April 13, 2018
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancerKyla A L Collins, Timothy J Stuhlmiller, Jon S Zawistowski, et al.
Elife|May 11, 2021
Limited inhibition of multiple nodes in a driver network blocks metastasisAli Ekrem Yesilkanal, Dongbo Yang, Andrea Valdespino, et al.
Molecular Cancer Therapeutics|February 5, 2025
Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastomaSmita Matkar, Michael P East, Timothy J Stuhlmiller, et al.
Antiviral Research|June 23, 2022
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategiesMarwah Karim, Sirle Saul, Luca Ghita, et al.
Neuro-Oncology|July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningiomaSteven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2026
Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancersMatthew D Sutcliffe, Kevin R Mott, Tulay Yilmaz-Swenson, et al.
Pageof 18